HomeCompareNMTAY vs JNJ

NMTAY vs JNJ: Dividend Comparison 2026

NMTAY yields 541.42% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NMTAY wins by $347.1K in total portfolio value
10 years
NMTAY
NMTAY
● Live price
541.42%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$367.1K
Annual income
$984.09
Full NMTAY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NMTAY vs JNJ

📍 NMTAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNMTAYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NMTAY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NMTAY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NMTAY
Annual income on $10K today (after 15% tax)
$46,020.57/yr
After 10yr DRIP, annual income (after tax)
$836.48/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NMTAY beats the other by $132.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NMTAY + JNJ for your $10,000?

NMTAY: 50%JNJ: 50%
100% JNJ50/50100% NMTAY
Portfolio after 10yr
$193.6K
Annual income
$905.94/yr
Blended yield
0.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NMTAY
No analyst data
Altman Z
-9.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NMTAY buys
0
JNJ buys
0
No recent congressional trades found for NMTAY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNMTAYJNJ
Forward yield541.42%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-50%5.8%
Portfolio after 10y$367.1K$20.0K
Annual income after 10y$984.09$827.78
Total dividends collected$221.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NMTAY vs JNJ ($10,000, DRIP)

YearNMTAY PortfolioNMTAY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$37,771$27,070.93$10,676$355.77+$27.1KNMTAY
2$88,195$47,780.09$11,407$389.39+$76.8KNMTAY
3$146,502$52,133.81$12,198$426.53+$134.3KNMTAY
4$197,225$40,467.52$13,056$467.62+$184.2KNMTAY
5$236,488$25,457.18$13,987$513.12+$222.5KNMTAY
6$267,306$14,264.07$14,998$563.56+$252.3KNMTAY
7$293,552$7,534.07$16,098$619.52+$277.5KNMTAY
8$317,967$3,866.26$17,295$681.69+$300.7KNMTAY
9$342,181$1,956.93$18,599$750.82+$323.6KNMTAY
10$367,118$984.09$20,022$827.78+$347.1KNMTAY

NMTAY vs JNJ: Complete Analysis 2026

NMTAYStock

Neometals Ltd engages in the development and commercialisation of sustainable processing solutions that recycle and recover critical materials from waste streams in Australia. The company operates through three segments: Lithium, Titanium/Vanadium, and Other. Its projects include the Barrambie Gold project covering an area of 505 square kilometers located in Sandstone, Western Australia; Lithium Chemicals project; Vanadium Recovery project, which produces vanadium pentoxide from steelmaking by-products. Neometals Ltd was incorporated in 2001 and is based in West Perth, Australia.

Full NMTAY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NMTAY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NMTAY vs SCHDNMTAY vs JEPINMTAY vs ONMTAY vs KONMTAY vs MAINNMTAY vs ABBVNMTAY vs MRKNMTAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.